leisure time -WSS

leisure time

author：focus 2025-09-02 08:21:46 - browse：35

Photo illustration with orange background of Desmond Padhi, PharmD, interim CEO, Latigo (center), with Latigo board chair Nancy Stagliano (left) and Westlake Village BioPartners founding managing director Sean Harper, M.D. (right) -- biotech coverage from STAT — Desmond Padhi, PharmD, interim CEO, Latigo (center), with Latigo board chair Nancy Stagliano (left) and Westlake Village BioPartners founding managing director Sean Harper, M.D. (right) Illustration: Christine Kao/STAT; Courtesy: Steve Shoffner & Michael Haber

After three years being incubated by California VC Westlake Village BioPartners, a new biotech launched Wednesday with $135 million and plans to compete with Vertex Pharmaceuticals.

The startup is called Latigo Biotherapeutics, and it’s launching having already started a Phase 1 trial for a non-opioid pain medicine, LTG-001. The oral therapy is designed to silence pain-signaling neurons by blocking a sodium channel called NaV 1.8.

Westlake had set out years ago to scout out new options for pain medicines, and found a research desert, according to founding managing director Sean Harper. But NaV 1.8 has emerged as a promising option because of its potential to be non-addictive and to lessen pain without affecting a person’s central nervous system, digestion, or heart rate, as opioids can. There were still few high-quality molecules in development that could be licensed from an academic lab or another drug company, so Westlake decided to develop its own.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Can gargling with Listerine treat gonorrhea of the mouth?

WSS

The effects of a landmark ruling on DNA ownership are becoming clearer

The effects of a landmark ruling on DNA ownership are becoming clearer

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

Biden praises World Series champion Astros for impact off the field during White House celebration

More regulation could be coming for drug ads

Zapping the brain for stroke rehab: Pivotal clinical trial begins

hotspot

leisure time

focus

Duchenne breakthrough therapy leaves behind pioneering families

Novel spinal cord stimulator treats paralysis without surgery

Medical records are filled with copy

Empower primary care with adequate payments and technology

At least 13 dead in Texas as scorching temps continue

GSK’s asthma push continues as drug succeeds in Phase 3 trials

After affirmative action ruling, medical educators look to 'holistic review'

An Ebola outbreak presents a new mystery involving children

New air purifier tech could be key to improving indoor air quality

Sage's campaign to raise awareness of postpartum depression hits a nerve

explore

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

FTX founder Sam Bankman

Biden praises World Series champion Astros for impact off the field during White House celebration

HHS's proposed rule does nothing to address the climate crisis

Discs beat pads, tampons for heavy menstrual flow, new study shows

Warren pushes Witty on UnitedHealth's control over physicians

focus

explore

entertainment

Wikipedia